Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pathobionts in Inflammatory Bowel Disease: Origins, Underlying Mechanisms, and Implications for Clinical Care
Ashley Gilliland, Jocelyn J Chan, Travis J. De Wolfe, et al.
Gastroenterology (2023) Vol. 166, Iss. 1, pp. 44-58
Open Access | Times Cited: 70

Showing 26-50 of 70 citing articles:

Identification of circadian rhythm-related biomarkers and development of diagnostic models for Crohn’s disease using machine learning algorithms
Zhijing Zhao, Xia Chen, Qian Xiang, et al.
Computer Methods in Biomechanics & Biomedical Engineering (2025), pp. 1-17
Closed Access
Adhesive polyelectrolyte coating through UV-triggered polymerization on PLGA particles for enhanced drug delivery to inflammatory intestinal mucosa
Jie Zhang, Yi‐jing Yin, Xing‐Wang Wang, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
Mechanistic investigation and the optimal dose based on baicalin in the treatment of ulcerative colitis–A preclinical systematic review and meta-analysis
Jinchen Chong, Zepeng Chen, Jiaze Ma, et al.
BMC Gastroenterology (2025) Vol. 25, Iss. 1
Open Access
The Role of M6A Modification in Autoimmunity: Emerging Mechanisms and Therapeutic Implications
Liyun Xu, Tian Shen, Yongzhen Li, et al.
Clinical Reviews in Allergy & Immunology (2025) Vol. 68, Iss. 1
Closed Access
Engineered Turmeric-Derived Nanovesicles for Ulcerative Colitis Therapy by Attenuating Oxidative Stress and Alleviating Inflammation
Guihong Lu, Shanming Lu, Haibing Dai, et al.
Molecular Pharmaceutics (2025)
Closed Access
Subtractive proteomics and reverse-vaccinology approaches for novel drug targets and designing a chimeric vaccine against Ruminococcus gnavus strain RJX1120
Hou Dingding, Sher Muhammad, Irfan Manzoor, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Therapeutic potential of Latilactobacillus curvatus CCFM1268 in colitis treatment: Insights from in vitro and in vivo studies
Meifang Xiao, Yuxuan Xia, Ying Chen, et al.
Food Bioscience (2024) Vol. 59, pp. 103913-103913
Closed Access | Times Cited: 3
Paeoniae Decoction restores intestinal barrier dysfunction by promoting the interaction between ILC3 and gut flora
Shaowei Huang, Qiujuan Ye, Anjiang Wang, et al.
Phytomedicine (2024) Vol. 132, pp. 155873-155873
Closed Access | Times Cited: 3
Diminished Immune Response and Elevated Abundance in Gut Microbe Dubosiella in Mouse Models of Chronic Colitis with GBP5 Deficiency
Y. Li, Wenxia Wang, Yuxuan Liu, et al.
Biomolecules (2024) Vol. 14, Iss. 7, pp. 873-873
Open Access | Times Cited: 3
Mouse adaptation of human inflammatory bowel diseases microbiota enhances colonization efficiency and alters microbiome aggressiveness depending on the recipient colonic inflammatory environment
Simon M. Gray, Anh D. Moss, Jeremy Herzog, et al.
Microbiome (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 3
An Overview of the Influence of Breastfeeding on the Development of Inflammatory Bowel Disease
Benjamin Bertin, Benoît Foligné, Delphine Ley, et al.
Nutrients (2023) Vol. 15, Iss. 24, pp. 5103-5103
Open Access | Times Cited: 8
Changes in HLA-B27 Transgenic Rat Fecal Microbiota Following Tofacitinib Treatment and Ileocecal Resection Surgery: Implications for Crohn’s Disease Management
Aurélie Blondeaux, Caroline Valibouze, Silvia Speca, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2164-2164
Open Access | Times Cited: 2
Mesenteric Lymphatic B Cells Migrate to the Intestine and Aggravate DSS-Induced Colitis via the CXCR5–CXCL13 Axis
Yu Zhang, Zhe Wu, Qinghe Zhao, et al.
Biology (2024) Vol. 13, Iss. 5, pp. 322-322
Open Access | Times Cited: 2
Dysbiosis in inflammatory bowel diseases: egg, not chicken
Eduard F. Stange
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 2
Designing biomaterials for the treatment of autoimmune diseases
Beikang Tang, Xiaoyan Xie, Juan Lu, et al.
Applied Materials Today (2024) Vol. 39, pp. 102278-102278
Closed Access | Times Cited: 2
Biologic therapy for ulcerative colitis associated with immune thrombocytopenia
Manabu Nagayama, Yohei Funayama, Osamu Taniguchi, et al.
Clinical Journal of Gastroenterology (2024) Vol. 17, Iss. 5, pp. 910-914
Closed Access | Times Cited: 2
Abelmoschi Corolla polysaccharides and related metabolite ameliorates colitis via modulating gut microbiota and regulating the FXR/STAT3 signaling pathway
Linhai He, Kaidi Chen, Zepeng Chen, et al.
International Journal of Biological Macromolecules (2024) Vol. 277, pp. 134370-134370
Open Access | Times Cited: 2
Unveiling the overlooked fungi: the vital of gut fungi in inflammatory bowel disease and colorectal cancer
Yilin Huang, Yang Wang, Xiaotian Huang, et al.
Gut Pathogens (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 2
Host–pathobiont interactions in Crohn’s disease
Roberta Caruso, Bernard C. Lo, Grace Chen, et al.
Nature Reviews Gastroenterology & Hepatology (2024)
Closed Access | Times Cited: 2
Gut microbiota and immune profiling of microbiota-humanised versus wildtype mouse models of hepatointestinal schistosomiasis
Klara A. Stark, Gaetana Rinaldi, Alice Costain, et al.
Animal Microbiome (2024) Vol. 6, Iss. 1
Open Access | Times Cited: 1
Untangling the role of the microbiome across the stages of HIV disease
Alexandra M. Ortiz, Jason M. Brenchley
Current Opinion in HIV and AIDS (2024) Vol. 19, Iss. 5, pp. 221-227
Open Access | Times Cited: 1
Probiotics in the Treatment of Inflammatory Bowel Diseases
Stefano Guandalini
Advances in experimental medicine and biology (2024), pp. 135-142
Closed Access | Times Cited: 1
Can Postbiotics Represent a New Strategy for NEC?
Maria Lorella Giannì, Daniela Morniroli, Fabio Mosca, et al.
Advances in experimental medicine and biology (2024), pp. 43-57
Closed Access | Times Cited: 1
Global, regional, and national burden of inflammatory bowel disease, 1990-2021: Insights from the global burden of disease 2021
Dao-po Lin, Jin Yang, Xiaoxiao Shao, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1
ACSL4 mediates inflammatory bowel disease and contributes to LPS-induced intestinal epithelial cell dysfunction by activating ferroptosis and inflammation
Ieng-Hou Lam, Chon-In Chan, Meixia Han, et al.
Open Medicine (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 1

Scroll to top